Table 5.
Inpatient Procedure | N (total) |
No 30-day Adverse Event (N=457) |
Experienced a 30-day Adverse Event (N=181) |
---|---|---|---|
Thoracentesis | 9 | 3 | 6 |
Insertion of Coronary artery stent |
14 | 12 | 2 |
Cardiac catheterization |
47 | 31 | 16 |
Electrophysiologic study |
9 | 9 | 0 |
Ablation | 11 | 9 | 2 |
Pacemaker Insertion | 26 | 20 | 6 |
Pacemaker Revision | 5 | 4 | 1 |
Hemodialysis | 14 | 12 | 2 |
Transthoracic Echocardiogram |
60 | 44 | 16 |
Transfusion of blood products |
51 | 31 | 20 |
Atrial cardioversion | 18 | 15 | 3 |
Other cardioversion | 31 | 25 | 6 |
Intubation | 14 | 7 | 7 |
Required continuous intravenous AV nodal blocking infusion in ED |
144 | 106 | 38 |